PNC Financial Services Group’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-60,280	Closed	-$120K	–	4185
2019 Q3	$120K	Hold	60,280	–	–	﹤0.01%	2440
2019 Q2	$130K	Buy	60,280 +3,400	+6%	+$8.69K	﹤0.01%	2413
2019 Q1	$180K	Buy	56,880 +940	+2%	+$3.04K	﹤0.01%	2205
2018 Q4	$140K	Buy	55,940 +1,280	+2%	+$4.26K	﹤0.01%	2270
2018 Q3	$220K	Sell	54,660 -1,100	-2%	-$4.85K	﹤0.01%	2142
2018 Q2	$210K	Buy	55,760 +4,560	+9%	+$11.9K	﹤0.01%	2155
2018 Q1	$118K	Sell	51,200 -200	-0.4%	-$316	﹤0.01%	2469
2017 Q4	$80K	Hold	51,400	–	–	﹤0.01%	2684
2017 Q3	$110K	Hold	51,400	–	–	﹤0.01%	2477
2017 Q2	$232K	Sell	51,400 -1,600	-3%	-$5.8K	﹤0.01%	2053
2017 Q1	$160K	Hold	53,000	–	–	﹤0.01%	2242
2016 Q4	$146K	Hold	53,000	–	–	﹤0.01%	2271
2016 Q3	$166K	Buy	53,000 +17,420	+49%	+$63.5K	﹤0.01%	2193
2016 Q2	$182K	Hold	35,580	–	–	﹤0.01%	2156
2016 Q1	$146K	Buy	35,580 +740	+2%	+$3.96K	﹤0.01%	2299
2015 Q4	$282K	Buy	34,840 +5,480	+19%	+$45.7K	﹤0.01%	1867
2015 Q3	$248K	Buy	29,360 +2,940	+11%	+$27.1K	﹤0.01%	1993
2015 Q2	$248K	Buy	26,420 +7,360	+39%	+$68.6K	﹤0.01%	2079
2015 Q1	$176K	Buy	19,060 +6,940	+57%	+$66.5K	﹤0.01%	2328
2014 Q4	$112K	Buy	12,120 +7,380	+156%	+$62.1K	﹤0.01%	2412
2014 Q3	$42K	Buy	+4,740	New	+$34.5K	﹤0.01%	2763

Other funds holding CORV